Mian Mohammed Khuram Shahzad MD PhD, MSc
Gynecologic Oncology
Senior Member/Associate Professor Moffitt Cancer Center / University of South Florida, School of Medicine
12902 Usf Magnolia DrTampa, FL 33612
Overview of Dr. Shahzad
Dr. Mian Shahzad is an obstetrician/gynecologist in Tampa, FL and is affiliated with multiple hospitals in the area, including H. Lee Moffitt Cancer Center and Research Institute and AdventHealth Tampa. He received his medical degree from Ross University School of Medicine and has been in practice 23 years. He is one of 98 doctors at AdventHealth Tampa and one of 89 doctors at H. Lee Moffitt Cancer Center and Research Institute who specialize in Obstetrics & Gynecology. He has more than 70 publications and over 500 citings.
Education & Training
University of Wisconsin Hospitals and ClinicsFellowship, Gynecologic Oncology, 2010 - 2013
University of Wisconsin-MadisonPhD, Endocrinology and Reproductive Physiology-focused in cancer biology, 2010 - 2013- University of Texas Graduate school of biomedical sciences/MD Anderson Cancer CenterMSc, Cancer Biology and Molecular Carcinogenesis, 2009 - 2010
Baylor College of MedicinePost-Doctoral Fellowship, 2007 - 2010
University of Texas M.D. Anderson Cancer CenterPost-Doctoral Fellowship, 2007 - 2010
Certifications & Licensure
FL State Medical License 2013 - 2027
WI State Medical License 2009 - 2013
NY State Medical License 2007 - 2011
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification PowerChart (CQM), Cerner Corporation, 2016-2017
- CMS Meaningful Use Stage 1 Certification FairWarning® Patient Privacy Monitoring, FairWarning Technologies, LLC, 2016-2017
- CMS Meaningful Use Stage 1 Certification PowerChart (Clinical), Cerner Corporation, 2016-2017
Publications & Presentations
PubMed
- 2 citationsAtezolizumab and Stereotactic Body Radiation in Metastatic, Recurrent, or Persistent Cervical Cancer: Results From a Phase 2 Multi-Institutional Study.Kamran A Ahmed, Allison M Quick, Hye Sook Chon, Jing-Yi Chern, Kristin Bixel
International Journal of Radiation Oncology, Biology, Physics. 2026-05-01 - A phase 2 study of pembrolizumab and weekly paclitaxel for platinum-resistant epithelial ovarian cancer.Robert M Wenham, Andrea L Buras, Sarah W Gordon, Junmin Whiting, Brooke L Fridley
International Journal of Gynecological Cancer. 2025-12-13 - Adnexal mass management by minimally invasive surgery at a comprehensive cancer center.Anna Quian, Ann Marie Mercier, Allison Akers, Robert M Wenham, Hye Sook Chon
Journal of Robotic Surgery. 2025-10-18
Press Mentions
Moffitt Doctors Say They're Closing in on Cures for Certain Common CancersFebruary 8th, 2022
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
